0000898432-20-000710.txt : 20200811 0000898432-20-000710.hdr.sgml : 20200811 20200811172139 ACCESSION NUMBER: 0000898432-20-000710 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200811 DATE AS OF CHANGE: 20200811 EFFECTIVENESS DATE: 20200811 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Concure Oncology, Inc. CENTRAL INDEX KEY: 0001607763 IRS NUMBER: 465134496 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-300882 FILM NUMBER: 201093412 BUSINESS ADDRESS: STREET 1: 3010 77TH AVENUE SE STREET 2: SUITE 206 CITY: MERCER ISLAND STATE: WA ZIP: 98040 BUSINESS PHONE: 206-275-3000 MAIL ADDRESS: STREET 1: 3010 77TH AVENUE SE STREET 2: SUITE 206 CITY: MERCER ISLAND STATE: WA ZIP: 98040 FORMER COMPANY: FORMER CONFORMED NAME: Breast Microseed, Inc. DATE OF NAME CHANGE: 20140509 D/A 1 primary_doc.xml X0708 D/A LIVE 0001607763 Concure Oncology, Inc. 3010 77TH AVENUE SE MERCER ISLAND WA WASHINGTON 98040 206-375-3000 DELAWARE Breast Microseed, Inc. Corporation true Scott Armstrong c/o Concure Oncology, Inc. 3010 77th Avenue SE Mercer Island WA WASHINGTON 98040 Executive Officer Director Craig Tall c/o Concure Oncology, Inc. 3010 77th Avenue SE Mercer Island WA WASHINGTON 98040 Director Chris Ackerley c/o Concure Oncology, Inc. 3010 77th Avenue SE Mercer Island WA WASHINGTON 98040 Director Other Health Care Decline to Disclose 06b true 0000898432-19-001169 2020-03-06 false true false 0 12058809 7461309 4597500 $2,402,500 of item 13(b) is cash investment, $5,058,809 of item 13(b) is the conversion of previously issued convertible notes. false 34 0 0 0 false Concure Oncology, Inc. /s/ Scott Armstrong Scott Armstrong President 2020-08-07